FATE compared with ADCT: revenue, margins and what each company keeps, and the suppliers and customers both name

FATEFate Therapeutics Inc

Mkt capRevenueRevenue

ADCTADC Therapeutics SA

Mkt capRevenueRevenue

Compare

FATEFate Therapeutics Inc

ADCTADC Therapeutics SA

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

FATEwithADCT

Uncorrelated: r 0.25 · 500D.

Shared co-movers2with FATEwith ADCT

RGNXRegenxbio Inc.r 0.38r 0.31

RXRXRecursion Pharmaceuticals, Inc.r 0.42r 0.26

FATE, solidADCT, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

FATEFate Therapeutics Inc

2.04· pre 2.04· delayed

Mkt cap$244.4MRevenue$2MQ2 FY26Revenue$7MFY25

ADCTADC Therapeutics SA

1.56· pre 1.56· delayed

Pre-marketNov 3 '26delayed

Mkt cap$197.9MRevenue$19MQ2 FY26Revenue$71MFY24

Compare

Pre-marketNov 3 '26delayed

FATEFate Therapeutics Inc

ADCTADC Therapeutics SA

2.04pre 2.04delayed

Price

1.56pre 1.56delayed

$244.4M

Mkt cap

$197.9M

Q2 FY26$2M

Revenue

$19MQ2 FY26

FY25$7M

Revenue

$71MFY24

FATE2.04vsADCT1.56Pre-marketNov 3 '26delayed